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Background: Guillain–Barré syndrome is an immune mediated acute inflammatory polyradiculo-neuropathy involving
the peripheral nervous system. Commonest presentation is acute or subacute flaccid ascending paralysis of limbs.
Rarely autonomic dysfunction can be the presenting feature of Guillain–Barré syndrome. Raynaud’s phenomenon,
although had been described in relation to many disease conditions, has not been described in association with
Guillain–Barré syndrome up to date.
Case presentation: We report the first case of Guillain–Barré syndrome presenting with Raynaud’s phenomenon in a
21-year-old previously well boy. New onset Raynaud’s phenomenon was experienced followed by acute ascending
flaccid paralysis of lower limbs and upper limbs together with palpitations and postural giddiness. Nerve conduction
studies showed acute inflammatory demyelinating polyneuropathy with cerebrospinal fluid cyto-protein dissociation.
He was treated with intravenous immunoglobulin and showed a satisfactory clinical recovery of muscle weakness,
Raynaud’s phenomenon and autonomic disturbances.
Conclusion: Guillain–Barré syndrome presenting with Raynaud’s phenomenon is not being reported in literature
previously. Although the underlying mechanism is not fully understood, Raynaud’s phenomenon should prompt the
physician to consider Guillain–Barré syndrome with a complimentary clinical picture.
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Guillain–Barré syndrome is an acute inflammatory
polyradiculo-neuropathy, an immune mediated disease
affecting the peripheral nervous system. It comprises
of a heterogeneous group of clinical entities. Usually it
is preceded by an antecedent event in two thirds of the
patients, commonly an infection [1,2]. Typical presentation
is of acute ascending flaccid paralysis of lower-limbs with
absent or diminished reflexes, extending more proximally
with time and proximal muscle groups being affected
more than the distal. Many patients experience paresthesia
with mild degree of sensory involvement. Cranial nerve
involvement is also not uncommon. Dysautonomia had
been described in 60% of the patients with Guillain–Barré
syndrome [3] manifesting with reduced or excess activa-
tion of sympathetic or parasympathetic nervous systems.
Rarely autonomic involvement can be the presenting
symptom in Guillain–Barré syndrome [2,4,5].* Correspondence: sonaligunatilake@gmail.com
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article, unless otherwise stated.Raynaud’s phenomenon is an exaggerated vasospastic
response to emotion or cold weather giving rise to tri-
phasic color change in the acral regions of the body [5,6].
Classic color changes are white (due to ischaemia from
vasospasms), blue (due to deoxygenation of blood) and
red (due to reperfusion). Variety of causes and associated
diseases have been described to give rise to Raynaud’s
phenomenon but an extensive literature survey did not
reveal Raynaud’s phenomenon in association with
Guillain–Barré syndrome. Herein, we report the first
case of Guillain–Barré syndrome manifesting with
Raynaud’s phenomenon as the presenting complaint.
Case presentation
A 21-year-old previously healthy male presented to
Teaching Hospital, Kandy, Sri Lanka in July 2013 with the
complaint of bluish discoloration of hands for 5 days
duration and subsequent weakness of limbs.
He had experienced repeated transient episodes of hand
discoloration, blanching followed by bluish discoloration.BioMed Central Ltd. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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several times per day with increasing in frequency. It
was not associated with pain, numbness or weakness of
the limbs, neck pain or radicular pain. Identified pre-
cipitant was cold environment, but was not associated
with emotional stress. There was no history of trauma.
He did not have recent weight loss, anorexia, fever, oral
ulcers, hair-loss, skin rashes, joint swelling or joint pain.
No similar episodes were observed in the past.
Five days after the onset of hand discoloration, he
noticed weakness of both lower limbs with difficulty in
walking which progressed to weakness of upper limbs,
predominantly the proximal parts. He was able to walk
with support without ataxia initially and his hand grip
was poor and dropped certain objects. The weakness
was progressive. There was no double vision, slurring of
speech, dysphagia or dyspnea. There was neither bladder
nor bowel involvement. He had tingling sensation of
fingers and toes at the onset of the weakness of limbs
but remained static. He did not have postural giddiness but
experienced intermittent palpitations. He denied excessive
sweating or hypersalivation. Raynaud’s phenomenon which
he experienced earlier was still present during this period
of illness. There was no preceding respiratory tract
illness or diarrhoeal illness. His past medical history was
not significant and there was no exposure to heavy
metals. He did not have any foreign travels or exposure
to tick bites. The patient denied any long term use of
medication and he was a non-smoker and did not con-
sume alcohol. He was unmarried & denied any sexual
misbehavior.
On examination, he was otherwise well looking male
with a body mass index of 21 kg/m2. Generalized weakness
of muscle groups were noted involving distal more than
the proximal in both upper and lower limbs (upper
limb: distal - grade 3/5, proximal – grade 4/5; lower
limb: distal – grade 2/5, proximal – 3/5). There was
generalized areflexia with hypotonia. Pupils were size 3,
equally reacting to light. Sensory system, cerebellar system,
cranial nerves and fundi were clinically normal. Raynaud’s
phenomenon was observed when hands were exposed to
cold. There were no digital ulcers or gangrene. Cardiovas-
cular system examination revealed a regular heart rate of
110/min with a postural drop in systolic blood pressure
(supine – 130/80; seated – 100/80). All peripheral pulses
were present with good volume and there were no sub-
clavian, carotid or femoral bruits. Respiratory, abdominal
and locomotor system examinations were normal.
His complete blood count, blood picture, renal and liver
profile were normal. Other basic investigations revealed;
erythrocyte sedimentation rate – 05 mm in 1st Hour,
C-reactive protein – normal, serum electrolytes including
Na+, K+, Ca2+ & Mg2+ were normal, serum proteins:
total– 7.8 g/dl, albumin - 4.6 g/dl, globulin - 3.1 g/dl.Fasting blood sugar and lipid profile were within normal
range. Cerebrospinal fluid (CSF) studies done on day
10 of the illness showed elevated proteins (120 mg/dl;
normal < 40 mg/dl) with 01 white cell, 100% being lym-
phocytes. CSF sugar was within normal limits compared
to plasma value. Nerve conduction studies revealed
focal segmental demyelinating type of neuropathy with
elevated distal motor latency, elongated F-wave, con-
duction block without axonal abnormalities, concluding
as acute inflammatory demyelinating polyneuropathy
(AIDP) type Guillain–Barré syndrome.
Further investigations showed negative serology for my-
coplasma, campylobacter jejuni, cytomegalovirus, Epstein-
Barr virus, hepatitis B & C and human immuno deficiency
virus (HIV). Anti-nuclear antibodies, anti-neutrophil anti-
bodies and rheumatoid factor were negative with normal
thyroid stimulating hormone levels. Serum protein electro-
phoresis was normal. X ray cervical spine, thoracic inlet
and chest x ray were negative for cervical ribs or any
significant pathology. Venous duplex scan of the upper
limbs showed good arterial flow without obstruction.
Electrocardiogram showed sinus tachycardia and arrhyth-
mias were not noted. He had normal echocardiogram
findings with no features suggesting myocarditis.
Based on the clinical and investigation findings, diagnosis
of Guillain–Barré syndrome was reached and intravenous
immunoglobulin 0.4 g/kg/day was administered for five
days. Patient showed good clinical response to treatment
and the muscle power improved to 4/5 in all muscle groups
during the ward stay, though the patient remained areflexic.
His symptoms of Raynaud’s phenomenon, palpitations and
postural giddiness showed dramatic improvement during
the ward stay and on discharge patient was free of symp-
toms. His pulse rate had reduced to 80 beats per minute
and blood pressure was 120/80 mmHg, both supine and
erect. He was followed up to six months and had com-
pletely recovered with normal muscle power with 1+ re-
flexes, and had not experienced Raynaud’s phenomenon
even with exposure to cold weather.
Discussion
Guillain–Barré syndrome is an immune mediated disease,
manifesting as an acute polyradiculo- neuropathy involving
the peripheral nervous system. Clinical manifestations
are preceded by an antecedent event in two thirds of the
patients [1,2], commonly an upper respiratory tract
infection or a diarrhoeal illness. Pathogenesis involves
production of auto antibodies against the infectious agent
that cross react against gangliosides and glycolipids (GM1
and GD1b) that are distributed along the myelin sheaths
of the peripheral nervous system. This causes defective
propagation of electrical impulses thus resulting in
marked delay or absence of electrical impulse along the
nerve fibers resulting in flaccid paralysis. There are several
Gunatilake and Wimalaratna BMC Neurology 2014, 14:174 Page 3 of 4
http://www.biomedcentral.com/1471-2377/14/174sub-types of Guillain–Barré syndrome identified depend-
ing on clinical presentation, involvement of the particular
nerves and pathology; (1) Acute inflammatory demyelinat-
ing poluneuropathy, (2) Acute motor axonal neuropathy,
(3) Acute motor sensory axonal neuropathy, (4) Miller
Fisher syndrome, (5) Acute panautonomic neuropathy
and (6) Pure sensory Guillain–Barré syndrome.
Patients with Guillain–Barré syndrome commonly
present with acute or sub-acute symmetrical weakness of
lower limbs with ascending paralysis extending to upper
limbs, neck muscles, bulbar muscles, cranial nerves and
respiratory muscles needing ventilatory support [2,7,8].
Muscle involvement is proximal more than the distal
muscle groups and commonly with diminished or absent
deep tendon reflexes. It is not uncommon to notice mild
paresthesia or pain by the patients.
Autonomic dysfunction is also seen in 60% of the
patients with Guillain–Barré syndrome [3]. Rarely it can be
the presenting manifestation of Guillain–Barré syndrome
[2,4,5]. Clinical features of dysautonomia commonly seen
in relation to cardiovascular system are sinus tachycardia,
sinus bradycardia, other cardiac arrhythmias (both tachy
and bradyarrythmias), hypertension, postural hypotension
and wide fluctuations of pulse and blood pressure.
Tonic pupils, hyper salivation, anhydrosis or excessive
sweating, urinary sphincter disturbances, constipation
and gastric dysmotility are recognized as a part of
autonomic dysfunction [3,9].
Raynaud’s phenomenon is the triad of pallor, cyanosis
and redness of the acral regions of the body (hands and
feet) due to episodic digital vasospasms. Classically it is
brought about by cold environment or emotions [10].
Pallor is a result of ischaemia due to vasospasms, cyanosis
due to deoxygenation of blood and redness being the
result of reperfusion following reversal of the spasms.
Two subtypes are described, primary Raynaud’s which is
not associated with any other illness and secondary
Raynaud’s phenomenon, where vasospasms are associated
with another disease, commonly autoimmune diseases,
mixed connective tissue disease and scleroderma. Patho-
genesis of primary Raynaud’s phenomenon is not fully
understood but vascular, intravascular and neural mecha-
nisms are proposed [6,11]. Of the neural mechanisms,
central impairment of the autonomic function resulting
in Raynaud’s phenomenon is suggested by the research
done by Koszewicz et al. [12]. Mallipeddi et al. concluded
that primary Raynaud’s phenomenon is associated with
sympathetic denervation in chronic autonomic failure
[10]. Sympathetic over-activity provoking vasospasm by
exaggerated vascular response is also suggested as one of
the mechanisms causing Raynaud’s phenomenon [11,13].
Hyperactivity of the α2c adrenorecepters is also postulated
as one of the mechanisms [6]. But experiments done by
Fagius et al. showed neither hypersensitivity of the vesselsto sympathetic bursts nor abnormal increase in sympa-
thetic outflow was present in patients with Raynaud’s
phenomenon [14]. Further studies are required for a
better knowledge regarding the contribution of sympa-
thetic nervous system or dysautonomia in Raynaud’s
phenomenon.
Although several etiologies are described in-relation to
Raynaud’s phenomenon as primary Raynaud’s’s disease,
occupational, haematological, autoimmune, connective
tissue diseases, vasculitis, thrombo-embolic disease,
carpal tunnel syndrome, thoracic outlet syndrome, reflex
sympathetic dystrophy, pheochromocytoma, acromegaly,
lung adenocarcinoma and Fabry s disease, extensive
literature survey did not reveal Raynaud’s phenomenon
in association with Guillain–Barré syndrome. Common
pathological features in both conditions are dysautonomia
with altered sympathetic activation.
The patient in this case report presented with Raynaud’s
phenomenon and subsequently developed features of
Guillain–Barré syndrome with further supportive evi-
dence from CSF and nerve conduction studies. He also
had other features of autonomic dysfunction as postural
hypotension. Weakness and neurological symptoms re-
solved following treatment for Guillain–Barré syndrome
and Raynaud’s phenomenon also resolved permanently.
Conclusion
We report the first case of Guillain–Barré syndrome pre-
senting with Raynaud’s phenomenon, which highlights the
importance of considering the possibility of Guillain–Barré
syndrome in a patient presenting with de novo Raynaud’s
phenomenon. More classic features of Guillain-Barre
syndrome may follow soon after. This is important for
close observation and prompt treatment. The exact
pathophysiological mechanisms linking above two entities
can be postulated as dysautonomia but need further
evaluation with experimental studies.
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